Atrial natriuretic peptide attenuates the development of pulmonary hypertension in rats adapted to chronic hypoxia.
To test the hypothesis that chronic infusion of atrial natriuretic peptide (ANP) instituted before hypoxic exposure attenuates the development of pulmonary hypertension in hypoxia adapted rats, ANP (0.2 and 1.0 microgram/h) or vehicle was administered intravenously via osmotic minipump for 4 wk begi...
Gardado en:
| Publicado en: | J Clin Invest |
|---|---|
| Principais autores: | , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
American Society for Clinical Investigation
1990
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC296394/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/2136863/ https://ncbi.nlm.nih.govhttps://doi.org/10.1172/JCI114400 |
| Tags: |
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|